CellaVision AB (publ) (CLVSF) Q2 2026 Earnings Call Transcript

Good morning, everyone, and thank you for joining us today. My name is Steve Ferguson, and with me is our Chief Financial Officer, Monica Jonsson. We appreciate you taking the time to join us this morning as we present CellaVision's results for the second quarter of 2026. Following the presentation, both Monica and I will be happy to take questions. As this is my first quarterly earnings call since joining CellaVision as CEO on June 5. I'd also like to take a moment just to very briefly introduce myself. Before joining CellaVision, I spent more than 25 years in international leadership roles across the life science diagnostics and health care industries. Most recently, I was serving CEO of Medix Biochemica in Finland, following senior commercial and operational leadership positions at Thermo Fisher Scientific or Phadia in Uppsala, and prior to that with Lundbeck based in Valby, Copenhagen. I'm really super excited to be part of CellaVision and to the challenge ahead, and I look forward to working together with our very talented team, our partners and all of you as we continue to build on the company's strong foundation to advance laboratory workflow, and diagnostic certainty through intelligent microscopy. I'm speaking to you this morning from Vancouver, where it's 2:00 a.m., so I'll do my best to keep our energy high during this call.